Published online Nov 24, 2015. doi: 10.5410/wjcu.v4.i3.108
Peer-review started: May 20, 2015
First decision: August 19, 2015
Revised: October 17, 2015
Accepted: November 13, 2015
Article in press: November 17, 2015
Published online: November 24, 2015
Processing time: 193 Days and 23.1 Hours
Continuous bladder irrigation (CBI) is commonly prescribed after certain prostate surgeries to help prevent the clot formation and retention that are frequently associated with these sometimes hemorrhagic surgeries. However, it remains unknown how effective CBI is in preventing clot formation/catheter blockage because these complications still frequently occur in the presence of CBI. On the other hand, the outcome of prostate surgeries has significantly improved over the years, and these surgeries have generally become much safer and, in many hands, less hemorrhagic. Newer surgical options such as holmium laser enucleation of the prostate with associated improved hemorrhagic control have also been introduced, further creating the opportunity to eliminate CBI. Furthermore, there is a lack of review articles on CBI. Hence, this article will review the evolution and contemporary role of CBI in prostate surgeries. To eliminate CBI after prostate surgeries, it is important to achieve good hemostasis during the surgeries. Having in place a policy of non-irrigation after prostate surgeries is also important if less CBI is to be the norm. A non-irrigation policy will hopefully help reduce those cases of CBI prescribed out of long-standing surgical tradition while allowing for cases prescribed out of compelling necessity. The author’s policy of a consistent non-CBI during prostate surgeries over the last 9 years will be highlighted.
Core tip: Continuous bladder irrigation (CBI) has been part and parcel of some prostate surgeries and might have been more relevant during the era of unpredictable hemostatic control. Hemostatic control during prostate surgeries has significantly improved, and new technologies with associated improved hemostasis have been introduced. Hence, CBI can be safely avoided in most prostate surgeries, especially when good hemostasis has been achieved and a policy to pursue the non- CBI pathway is in place.